Observational study to evaluate the actual use of Dymista® nasal spray in different allergic rhinitis patient phenotypes

Study type

• Study topic:
  Disease /health condition

  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Effectiveness study (incl. comparative)
• Data collection methods:
  Primary data collection

Non-interventional study

• Non-interventional study design:
  Other
• Non-interventional study design, other:
  Non-interventional study

Study drug and medical condition

• Study drug International non-proprietary name (INN) or common name:
  AZELASTINE HYDROCHLORIDE

  FLUTICASONE PROPIONATE
• Medical condition to be studied:
  Rhinitis allergic

Population studied

• Short description of the study population:
  Patients who were getting the same prescription for allergic treatment for the first time in routine clinical practice.
• Age groups:
  • Paediatric Population (< 18 years)

    • Adolescents (12 to < 18 years)
  • Adult and elderly population (≥18 years)

    • Adults (18 to < 65 years)

      • Adults (18 to < 46 years)
      • Adults (46 to < 65 years)
    • Elderly (≥ 65 years)

      • Adults (65 to < 75 years)
      • Adults (75 to < 85 years)
      • Adults (85 years and over)
• Special population of interest:
  Other
• Special population of interest, other:
  Rhinitis allergic patients
• Estimated number of subjects:
  1500

Study design details

• Main study objective:
  To gather knowledge on patient phenotypes getting the same prescription for allergic treatment for the first time in routine clinical practice. The response to therapy in routine clinical practice, quality of sleep as well as troublesomeness in daily activities will be assessed by means of a Visual Analogue Scale (VAS).
• Data analysis plan:
  All variables will be analysed by means of adequate descriptive statistics.